Felice C Lightstone Selected Research

jiadifenolide

1/2018

Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felice C Lightstone Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 10/2005
4	Lymphoma (Lymphomas) 11/2007 - 08/2007
3	Poisoning 01/2021 - 06/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 07/2010 - 08/2007
3	Leukemia 10/2007 - 08/2007
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2007 - 12/2006
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2018
1	Dementia (Dementias) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Cardiotoxicity 01/2017
1	Aneurysm (Aneurysms) 01/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2014
1	Bacterial Infections (Bacterial Infection) 01/2013
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2010
1	Melanoma (Melanoma, Malignant) 10/2010
1	Neoplasm Metastasis (Metastasis) 10/2010
1	Glioblastoma (Glioblastoma Multiforme) 10/2010
1	Bone Resorption 10/2010
1	Breast Neoplasms (Breast Cancer) 10/2005
1	Tetanus 10/2002

Drug/Important Bio-Agent (IBA)

5	LigandsIBA 12/2018 - 12/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Radioisotopes (Radionuclides)IBA 10/2007 - 12/2006
2	Nerve AgentsIBA 01/2021 - 11/2017
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2014
2	IntegrinsIBA 10/2010 - 11/2007
2	Integrin alpha4beta1 (VLA-4)IBA 07/2010 - 01/2009
2	Urea (Carbamide)FDA LinkGeneric 01/2009 - 11/2007
2	PeptidomimeticsIBA 01/2009 - 11/2007
2	Cell Surface ReceptorsIBA 01/2009 - 11/2007
2	HLA-DR10 antigenIBA 10/2007 - 09/2007
2	AntibodiesIBA 10/2007 - 08/2007
1	AntidotesIBA 01/2021
1	ras ProteinsIBA 01/2020
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	SesquiterpenesIBA 01/2018
1	jiadifenolideIBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Nootropic Agents (Nootropics)IBA 01/2018
1	ConvulsantsIBA 01/2018
1	Memantine (Namenda)FDA Link 01/2018
1	RodenticidesIBA 06/2014
1	tetramethylenedisulfotetramine (DSTA)IBA 06/2014
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	CY5.5 cyanine dyeIBA 10/2010
1	StreptavidinIBA 10/2010
1	aspartic acid glycine arginineIBA 10/2010
1	benzimidazoleIBA 07/2010
1	benzothiazoleIBA 01/2009
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2007
1	HLA-DR Antigens (HLA-DR)IBA 08/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2007
1	Monoclonal AntibodiesIBA 12/2006
1	CarcinogensIBA 10/2005
1	AminesIBA 10/2005
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 10/2005
1	Estrogen Receptor alphaIBA 10/2005
1	Estrogen ReceptorsIBA 10/2005
1	NeurotoxinsIBA 10/2002
1	GangliosidesIBA 10/2002

Therapy/Procedure

3	Therapeutics 01/2018 - 09/2007
2	Radiotherapy 10/2007 - 08/2007
1	Radioimmunotherapy 09/2007